New appearance for the global brand VivaScope.
May 2023 – VivaScope is proud to announce its new modern brand appearance. This refreshed look is a reflection of our commitment to innovation, technology, and customer service.
Take a closer look:
Our new brand appearance combines modern design elements and innovative technology to create a seamless and user-friendly experience for all of our customers. The sleek and sophisticated design of our new brand identity reflects our commitment to staying at the forefront of the ever-changing technology landscape. “We are excited to unveil our new modern brand appearance,” says Giuseppe Solomita, Director Sales & Marketing.
New emblem
Focusing on white color. For flexible use in multiple platforms.
We invite you to experience our new modern brand appearance and to discover the innovative technology that we have to offer.
New print layout.
With the two color scheme.
This refresh is a testament to our dedication to innovation and excellence in all aspects of our business.
Website.
Modern & intuitiv.
The new brand appearance will be launched across all of our platforms, including our website, social media, and marketing materials. We are confident that our new look will help us to continue to excel in the global technology industry.
Attachements
Contact Person:
News
RAI 1 Highlights VivaScope In Vivo: Advancing Real-Time, Non-Invasive Skin Cancer Diagnostics
Munich / Italy, May 2026 – Italian national broadcaster RAI 1 recently featured VivaScope In Vivo technology in a television segment dedicated to innovations in dermatological diagnostics. The report showcased a live patient examination, demonstrating how confocal microscopy enables real-time evaluation of skin lesions without the need for invasive tissue removal.
News
Analyse coût-bénéfice de la microscopie confocale en réflectance In Vivo pour le diagnostic du mélanome en situation clinique réelle
Dans cette publication, les auteurs ont cherché à appliquer une analyse coût-bénéfice à l’aide d’une approche de micro-coût sur les résultats de leur essai clinique randomisé, afin de démontrer l’impact économique du VivaScope® 1500 dans la pratique clinique courante. Ce modèle a été appliqué à des données régionales et nationales pour estimer des analyses coût-bénéfice à plus grande échelle.
News
Kosten-Nutzen-Analyse der In Vivo-Reflektanzkonfokalmikroskopie zur Melanomdiagnose in einem klinischen Alltagsszenario
In dieser Veröffentlichung verfolgten die Autoren das Ziel, eine Kosten-Nutzen-Analyse mittels eines Mikro-Kostenansatzes auf die Ergebnisse ihrer randomisierten klinischen Studie anzuwenden, um die wirtschaftlichen Auswirkungen des VivaScope® 1500 in der routinemäßigen klinischen Praxis aufzuzeigen. Dieses Modell wurde auf regionale und nationale Daten angewendet, um eine breitere Kosten-Nutzen-Analyse zu ermöglichen.